文献速递衰弱、肌少症与跌倒老年综合评估

表观遗传与代谢组学生物年龄标志物:死亡与衰弱风险的比较分析

Epigenetic and Metabolomic Biomarkers for Biological Age: A Comparative Analysis of Mortality and Frailty Risk.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2023-01-01

以生物生理和/或死亡信息训练的分子标志物在衰弱反映和死亡预测上优于仅以年龄训练的分子标志物;DNAm GrimAge和MetaboHealth与衰弱及死亡的关联最强,且两者相互独立并与模拟临床老年评估的衰弱评分独立。表观遗传、代谢组和临床生物年龄标志物似乎捕捉了衰老的不同方面。

要点

  • DNAm GrimAge和MetaboHealth与衰弱及死亡的关联最强且相互独立。
  • 以死亡信息训练的分子标志物在衰弱和死亡预测上优于年龄训练的分子标志物。
  • 表观遗传、代谢组和临床生物年龄标志物似乎捕捉衰老的不同方面。

核心结论

  • 以死亡信息训练的分子标志物在衰弱反映和死亡预测上优于仅以年龄训练的分子标志物。
  • DNAm GrimAge和MetaboHealth与衰弱和死亡的关联独立于彼此及模拟临床老年评估的衰弱评分。
  • 表观遗传、代谢组和临床生物年龄标志物似乎捕捉衰老的不同方面。

主要发现

  • DNAm GrimAge和MetaboHealth(以死亡信息训练)在衰弱反映和死亡预测上表现出最强关联。
  • DNAm GrimAge和MetaboHealth与衰弱及死亡的关联相互独立,且独立于模拟临床老年评估的衰弱评分。
  • 表观遗传、代谢组和临床生物年龄标志物似乎捕捉衰老的不同方面。

临床怎么用

  • 以死亡信息训练的分子标志物可能提供反映生物年龄的新表型,并加强当前临床老年健康与福祉评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Biological age captures a person's age-related risk of unfavorable outcomes using biophysiological information. Multivariate biological age measures include frailty scores and molecular biomarkers. These measures are often studied in isolation, but here we present a large-scale study comparing them. In 2 prospective cohorts (n = 3 222), we compared epigenetic (DNAm Horvath, DNAm Hannum, DNAm Lin, DNAm epiTOC, DNAm PhenoAge, DNAm DunedinPoAm, DNAm GrimAge, and DNAm Zhang) and metabolomic-based (MetaboAge and MetaboHealth) biomarkers in reflection of biological age, as represented by 5 frailty measures and overall mortality. Biomarkers trained on outcomes with biophysiological and/or mortality information outperformed age-trained biomarkers in frailty reflection and mortality prediction. DNAm GrimAge and MetaboHealth, trained on mortality, showed the strongest association with these outcomes. The associations of DNAm GrimAge and MetaboHealth with frailty and mortality were independent of each other and of the frailty score mimicking clinical geriatric assessment. Epigenetic, metabolomic, and clinical biological age markers seem to capture different aspects of aging. These findings suggest that mortality-trained molecular markers may provide novel phenotype reflecting biological age and strengthen current clinical geriatric health and well-being assessment.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Kuiper LM, Polinder-Bos HA, Bizzarri D, et al. Epigenetic and Metabolomic Biomarkers for Biological Age: A Comparative Analysis of Mortality and Frailty Risk. J Gerontol A Biol Sci Med Sci. 2023. PMID: 37303208. doi:10.1093/gerona/glad137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。